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volved. Fate of the cells after process is done is one of the raised questions. Usually 
degradation of one cell is seen.
In some epithelial tumors of the kidney emperipoplesis was observed. In the last 
5 years an entity called biphasic squamoid-alveolar carcinoma of the kidney was 
described and it has characteristics of papillary renal cell carcinoma with emperi-
polesis in the near proximity of large cells. The significance of this process in the 
kidney tumors has not yet been fully clarified.
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Survivin is a member of the inhibitor of apoptosis (IAP) family. It is also involved 
in the regulation of cell division. Survivin is widely expressed in foetal tissues and 
in human cancers, but generally not in normal adult tissue. Apoptosis is the process 
of programmed cell death where senescent or damaged cells that are beyond repair 
are eliminated. It is a cascade of molecular events regulated by proteins that pro-
mote or prevent cell death. It is believed to be an important mechanism by which 
therapeutic chemotherapy and radiation therapy destroy cancer cells. Survivin is an 
anti-apoptotic protein that is overexpressed in most human cancers. Survivin regu-
lates the G2/M phase of the cell cycle by associating with mitotic spindle microtubu-
les, and it directly inhibits caspase-3 and caspase-7 activity. During tumorigenesis, 
survivin expression is inversely correlated with apoptosis inhibition and positively 
correlated with proliferation and angiogenesis. In our previous research, we ob-
served immunohistochemical results of survivin and the relation between survi-
vin and proliferative index Ki-67 in 50 cases of breast cancer in accordance with 
immunophenotype by St.Galen (2015g.). Survivin immunoreactivity was evaluated 
semiquantitatively according to the previous studies.  Nuclear and cytoplasmic tu-
mour cell immunoreactivities were separately assessed  at 40 magnification, and 
were given an arbitrary score as follows: 0(0-5% positive cells); 1(5–20%); 2(21–50%); 
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3(51–75%); 4(>76%). A cutoff value of 20% was established as a positive result. Immu-
nohistochemical analysis showed positive expression for survivin in 18 of 50 cases 
(36%) of breast carcinomas of TNM stages I to III. What we should emphasize in our 
study is the correlation between Her 2-positive tumours and survivin expression 
(p=0,007). What we can interpretate in our research is, that survivin is not expre-
ssed in luminal A or luminal B types of tumours, and its expression in nucleus is 
an indicator of better prognosis which is consistent with previous studies. Strong 
association of survivin expression in cytoplasm in Her-2 positive tumours is a pre-
dictor of unfavourable outcome. What stays unclear in our study is lack of survivin 
expression in triple negative tumour types, or positivity in small sized tumours 
which does not comply with results in previous studies. Our goal is to make larger 
study that would comprise 30 cases of HER-2 positive and 30 cases of triple negative 
tumors. We want to compare survivin immunoreactivity and proliferative index Ki-
67 with other prognostic parameters such as tumor size, age of the patients, tumor 
grade and oestrogen receptor immunoreactivity.
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